To deny this as self-indulgence is to misread not just the emotional landscape of dementia, but its existential core: the ...

Alzheimer's disease (AD) is a debilitating neurodegenerative condition that affects a significant proportion of older people ...

INmune Bio's Alzheimer's drug falls short of mid-stage study goal, shares tumble INmune Bio said on Monday its experimental Alzheimer's drug failed to improve cognitive functions in patients with ...

Brain-related diseases are more sensitive than other diseases due to several factors, including the complexity of surgical procedures, high costs, and other challenges. Alzheimer’s disease is a common ...

NEW YORK (AP) — Bill Moyers, the former White House press secretary turned prize-winning TV journalist, has died at 91.

Anna Wintour stepping down as Vogue editor-in-chief, but will retain editorial control over the storied magazine.

The successful development of amyloid-based biomarkers and tests for Alzheimer's disease (AD) represents an important milestone in AD diagnosis. However, two major limitations remain. Amyloid-based ...

HONG KONG SAR - Media OutReach Newswire - 6 December 2023 - A research team led by Hong Kong Baptist University (HKBU) has developed a novel drug delivery system for Alzheimer's disease (AD). The ...

The challenges in the current treatment landscape for Alzheimer’s disease (AD) underscore the urgent need for novel therapeutic strategies targeting multiple pathological pathways. Recent studies have ...